611 related articles for article (PubMed ID: 18195716)
1. Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?
Le Hellard S; Theisen FM; Haberhausen M; Raeder MB; Fernø J; Gebhardt S; Hinney A; Remschmidt H; Krieg JC; Mehler-Wex C; Nöthen MM; Hebebrand J; Steen VM
Mol Psychiatry; 2009 Mar; 14(3):308-17. PubMed ID: 18195716
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in SREBF1 and SREBF2, two antipsychotic-activated transcription factors controlling cellular lipogenesis, are associated with schizophrenia in German and Scandinavian samples.
Le Hellard S; Mühleisen TW; Djurovic S; Fernø J; Ouriaghi Z; Mattheisen M; Vasilescu C; Raeder MB; Hansen T; Strohmaier J; Georgi A; Brockschmidt FF; Melle I; Nenadic I; Sauer H; Rietschel M; Nöthen MM; Werge T; Andreassen OA; Cichon S; Steen VM
Mol Psychiatry; 2010 May; 15(5):463-72. PubMed ID: 18936756
[TBL] [Abstract][Full Text] [Related]
3. Association of HTR2C, but not LEP or INSIG2, genes with antipsychotic-induced weight gain in a German sample.
Opgen-Rhein C; Brandl EJ; Müller DJ; Neuhaus AH; Tiwari AK; Sander T; Dettling M
Pharmacogenomics; 2010 Jun; 11(6):773-80. PubMed ID: 20504252
[TBL] [Abstract][Full Text] [Related]
4. Drug-induced activation of SREBP-controlled lipogenic gene expression in CNS-related cell lines: marked differences between various antipsychotic drugs.
Fernø J; Skrede S; Vik-Mo AO; Håvik B; Steen VM
BMC Neurosci; 2006 Oct; 7():69. PubMed ID: 17052361
[TBL] [Abstract][Full Text] [Related]
5. Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle.
Basile VS; Masellis M; McIntyre RS; Meltzer HY; Lieberman JA; Kennedy JL
J Clin Psychiatry; 2001; 62 Suppl 23():45-66. PubMed ID: 11603885
[TBL] [Abstract][Full Text] [Related]
6. Association study of polymorphisms in insulin induced gene 2 (INSIG2) with antipsychotic-induced weight gain in European and African-American schizophrenia patients.
Tiwari AK; Zai CC; Meltzer HY; Lieberman JA; Müller DJ; Kennedy JL
Hum Psychopharmacol; 2010 Apr; 25(3):253-9. PubMed ID: 20373477
[TBL] [Abstract][Full Text] [Related]
7. Association between SCAP and SREBF1 gene polymorphisms and metabolic syndrome in schizophrenia patients treated with atypical antipsychotics.
Yang L; Chen J; Li Y; Wang Y; Liang S; Shi Y; Shi S; Xu Y
World J Biol Psychiatry; 2016 Sep; 17(6):467-74. PubMed ID: 26982812
[TBL] [Abstract][Full Text] [Related]
8. Association between SREBF2 gene polymorphisms and metabolic syndrome in clozapine-treated patients with schizophrenia.
Yang L; Chen J; Liu D; Yu S; Cong E; Li Y; Wu H; Yue Y; Zuo S; Wang Y; Liang S; Shi Y; Shi S; Xu Y
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan; 56():136-41. PubMed ID: 25201120
[TBL] [Abstract][Full Text] [Related]
9. Association study of energy homeostasis genes and antipsychotic-induced weight gain in patients with schizophrenia.
Jassim G; Fernø J; Theisen FM; Haberhausen M; Christoforou A; Håvik B; Gebhardt S; Remschmidt H; Mehler-Wex C; Hebebrand J; Lehellard S; Steen VM
Pharmacopsychiatry; 2011 Jan; 44(1):15-20. PubMed ID: 20821366
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotic drugs activate SREBP-regulated expression of lipid biosynthetic genes in cultured human glioma cells: a novel mechanism of action?
Fernø J; Raeder MB; Vik-Mo AO; Skrede S; Glambek M; Tronstad KJ; Breilid H; Løvlie R; Berge RK; Stansberg C; Steen VM
Pharmacogenomics J; 2005; 5(5):298-304. PubMed ID: 16027736
[TBL] [Abstract][Full Text] [Related]
11. -759 C/T polymorphism of 5-HT2C receptor gene and early phase weight gain associated with antipsychotic drug treatment.
Ryu S; Cho EY; Park T; Oh S; Jang WS; Kim SK; Lee D; Hong KS
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):673-7. PubMed ID: 17275977
[TBL] [Abstract][Full Text] [Related]
12. Is rs7566605, a SNP near INSIG2, associated with body mass in a randomized clinical trial of antipsychotics in schizophrenia?
Skelly T; Pinheiro AP; Lange LA; Sullivan PF
Mol Psychiatry; 2007 Apr; 12(4):321-2. PubMed ID: 17389899
[No Abstract] [Full Text] [Related]
13. Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives.
Baptista T; Kin NM; Beaulieu S; de Baptista EA
Pharmacopsychiatry; 2002 Nov; 35(6):205-19. PubMed ID: 12518268
[TBL] [Abstract][Full Text] [Related]
14. [Antipsychotic-induced weight gain--pharmacogenetic studies].
Olajossy-Hilkesberger L; Godlewska B; Marmurowska-Michałowskal H; Olajossy M; Landowski J
Psychiatr Pol; 2006; 40(5):1009-20. PubMed ID: 17217242
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of INSIG2, MC4R, and LEP are associated with obesity- and metabolic-related traits in schizophrenic patients.
Kuo PH; Kao CF; Chen PY; Chen CH; Tsai YS; Lu ML; Huang MC
J Clin Psychopharmacol; 2011 Dec; 31(6):705-11. PubMed ID: 22020349
[TBL] [Abstract][Full Text] [Related]
16. HTR2C haplotypes and antipsychotics-induced weight gain: X-linked multimarker analysis.
De Luca V; Müller DJ; Hwang R; Lieberman JA; Volavka J; Meltzer HY; Kennedy JL
Hum Psychopharmacol; 2007 Oct; 22(7):463-7. PubMed ID: 17702092
[TBL] [Abstract][Full Text] [Related]
17. The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia.
Müller DJ; Klempan TA; De Luca V; Sicard T; Volavka J; Czobor P; Sheitman BB; Lindenmayer JP; Citrome L; McEvoy JP; Lieberman JA; Honer WG; Kennedy JL
Neurosci Lett; 2005 May; 379(2):81-9. PubMed ID: 15823421
[TBL] [Abstract][Full Text] [Related]
18. Association study between variants of AMP-activated protein kinase catalytic and regulatory subunit genes with antipsychotic-induced weight gain.
Souza RP; Tiwari AK; Chowdhury NI; Ceddia RB; Lieberman JA; Meltzer HY; Kennedy JL; Müller DJ
J Psychiatr Res; 2012 Apr; 46(4):462-8. PubMed ID: 22305490
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms of the LEP- and LEPR gene and obesity in patients using antipsychotic medication.
Gregoor JG; van der Weide J; Mulder H; Cohen D; van Megen HJ; Egberts AC; Heerdink ER
J Clin Psychopharmacol; 2009 Feb; 29(1):21-5. PubMed ID: 19142102
[TBL] [Abstract][Full Text] [Related]
20. Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia.
Popovic V; Doknic M; Maric N; Pekic S; Damjanovic A; Miljic D; Popovic S; Miljic N; Djurovic M; Jasovic-Gasic M; Dieguez C; Casanueva FF
Neuroendocrinology; 2007; 85(4):249-56. PubMed ID: 17570902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
